Clinical Trials on Moderate/Severe Atopic Dermatitis in France

Total 151 results

Inmagene LLC

Terminated

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Atopic Dermatitis | Moderate-to-severe Atopic Dermatitis | AD

Canada, United States
Galderma R&D

Completed

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
Galderma R&D

Active, not recruiting

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
Ad scientiam

Completed

Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy (ACTISLEEP)

Atopic Dermatitis Eczema

France
Ipsen

Completed

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines (BTX-A-HAC NG)

Moderate to Severe Glabellar Lines

France, Germany
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis (SHADOW)

Atopic Dermatitis

France
Central Hospital, Nancy, France

Completed

Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

Atopic Dermatitis

France
Pierre Fabre Dermo Cosmetique

Completed

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

Atopic Dermatitis

France
Hospices Civils de Lyon

Completed

Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients (METHODA)

Atopic Dermatitis

France
Centre Hospitalier Universitaire de Nice

Recruiting

Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE)

Atopic Dermatitis

France
University Hospital, Toulouse

Completed

Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis (IMMCEPTION)

Atopic Dermatitis

France
Nantes University Hospital

Completed

Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence (DACE)

Atopic Dermatitis

France
Hospices Civils de Lyon

Recruiting

Staphylococcus Aureus in Atopic Dermatitis Immunopathology (STADE)

Atopic Dermatitis

France
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Belgium, France, Germany, Italy, Spain, United Kingdom
Nantes University Hospital
UCB Biopharma SRL; Plateforme CIMNA, Laboratoire d'Immunologie, Nantes University...

Completed

The Role of IL-22/IL-22BP Axis in Atopic Dermatitis (DA/IL-22BP)

Atopic Dermatitis

France
University Hospital, Brest

Terminated

Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age (PRURINEO)

Atopic Dermatitis

France
Centre Hospitalier Universitaire de Besancon
University of Franche-Comté

Terminated

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis (MicroIskin)

Atopic Dermatitis

France
University Hospital, Lille

Enrolling by invitation

Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis (JAKIGREAT)

Dermatitis, Atopic

France
University Hospital, Lille

Recruiting

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis (PAUPIAD)

Atopic Dermatitis

France
PiLeJe

Completed

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

France
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Germany, France, Belgium, Spain, United Kingdom
United Pharmaceuticals

Active, not recruiting

Evaluation of an Adapted Formula on Atopic Dermatitis.

Atopic Dermatitis

Belgium, France
Institut National de la Santé Et de la Recherche...
Ministry of Health, France

Completed

IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis (IDA-Adult)

Atopic Dermatitis

France
University Hospital, Brest
Beiersdorf

Completed

Effects of an Anti-TRPM8 in the Atopic Dermatitis Pruritus (DA-TRPM8)

Atopic Dermatitis

France
Novartis Pharmaceuticals

Completed

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Atopic Dermatitis

Germany, Austria, France
Sanofi
Regeneron Pharmaceuticals

Recruiting

A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab (DUPILAB)

Atopic Dermatitis

France
Santen SAS

Completed

Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome

Moderate to Severe Dry Eye Syndrome

France
Pierre Fabre Dermo Cosmetique

Unknown

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

Healthy | Rosacea | Seborrheic Dermatitis | Atopic Dermatitis | Psoriasis Vulgaris | Acne

France
Nantes University Hospital

Recruiting

Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children (PREGRALL)

Dermatitis, Atopic

France
University Hospital, Rouen

Completed

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis (Disease)

Severe Seborrheic Dermatitis

France
Nantes University Hospital

Recruiting

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis (MADULO)

Atopic Dermatitis | Eczema, Atopic

France, Réunion
Nantes University Hospital

Terminated

A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months (EDUDA)

Dermatitis, Atopic

France
Association pour la Recherche Clinique et Immunologique

Unknown

Dupilumab Impact on Skin Resident Memory T Cells (DupiTrem)

Atopic Dermatitis

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Meditation in Inflammatory Dermatosis (MediDermIn)

Psoriasis | Pruritus | Atopic Dermatitis

France
Assistance Publique - Hôpitaux de Paris
SYNELVIA; WIRED BEAUTY Technologies

Not yet recruiting

Electrochemistry Measurement of Skin Hydration Parameters (SKINBIOSENSE)

Atopic Dermatitis | Acne | Skin Electrochemistry

France
Nantes University Hospital
LEO Pharma

Not yet recruiting

Ophthalmological Adverse Events of Tralokinumab in AD (TRALO-Oeil)

Atopic Dermatitis

France
Pfizer

Terminated

Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
LEO Pharma

Completed

Assessment of the Phototoxic Potential of LEO 29102 Cream

Atopic Dermatitis

France
LEO Pharma

Active, not recruiting

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Atopic Dermatitis

Spain, United Kingdom, Czechia, France, Netherlands
Rennes University Hospital

Completed

PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo (PRADA)

Atopic Dermatitis

France
Pierre Fabre Medicament

Completed

Emollients in the Management of Atopic Dermatitis

Atopic Dermatitis

France, Romania, Estonia, Poland, Lithuania
Pfizer

Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. (ADAIR)

Eczema | Atopic Dermatitis

France
Regeneron Pharmaceuticals
Sanofi

Completed

Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

Poland, Germany, France, Hungary, Czechia
LEO Pharma

Completed

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Atopic Dermatitis

United States, France, Netherlands
OM Pharma SA

Terminated

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Atopic Dermatitis

Germany, France, Poland, Netherlands
Centre Hospitalier Universitaire de Nice

Completed

Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis

Psoriasis | Atopic Dermatitis

France
Novartis Pharmaceuticals

Completed

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis

Germany, Czechia, France, Hungary, Spain, Poland
University Hospital, Bordeaux

Not yet recruiting

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata (INFLAMMAVit)

Psoriasis | Atopic Dermatitis | Vitiligo | Alopecia Areata

France
Bayer

Completed

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis (Damask)

Atopic Dermatitis

France, Czechia, Italy, Poland, United States, Germany, United Kingdom

3

Subscribe